Frontlight ResearchEarly access
CompletedNo phase
Transcutaneous Pulsed Radiofrequency Application Plus Genicular Nerve Block Versus Intraarticular Hyaluronic Acid Injection for Management of Chronic Pain in Knee Osteoarthritis.
Key facts
- Who runs it
- Tanta University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 80 people enrolled
- Started
- 1 Aug 2023
- Ended
- 1 Jul 2024
- Type of study
- Interventional, 2 groups
- Treatments tested
- Hyaluronic acid
- Transcutaneous pulsed radiofrequency
- Record updated
- 29 November 2024
Who can take part
- Age
- 40 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Aged above 40 years
- Both sexes
- American Society of Anesthesiologists (ASA)physical status I and II
- Patients radiologically proven symptomatic knee joint osteoarthritis not responding to medical treatment
- Patients with knee pain of moderate or greater intensity on most or all days for ≥ 3 months, showing significant radiological osteoarthritis (Kellgren-Lawrence grade 1 to 3); Radiological severity was assessed using the Kellgrenand Lawrence global scale as follow: Grade 0; means absence of radiological finding; grade 1: suspected narrowing of joint space; grade 2 refers to osteophytes and possible narrowing; grade 3 is defined as multiple os-teophytes, definite narrowing of joint space and grade 4 comprises large osteophytes, marked narrowing of joint space
Who cannot take part
- Patients who show improvement on medical treatment, patients on an oral, topical, or intra-articular steroid during the 4 weeks before the study; patients with an oral, topical, or suppository non-steroidal anti-inflammatory drugs within 2 weeks before the study
- Patients with joint replacement surgery in either knee and/or a hip
- Patients with meniscal tear, ligament injury, bursitis, and popliteal cyst and blood investigations suggestive of any infection
- Infection at site of injection
- Bleeding diathesis and coagulopathy
- Patient refusal
- Patients having secondary knee osteoarthritis
- Patients with severe osteoarthritis.(K/L grade >3) in a location other than the knee joint
- Patients with rheumatoid arthritis
- Morbid obese patients (body mass index (BMI) of >40 kg/m2)
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of the present study is to compare the analgesic efficacy of combined transcutaneous pulsed radiofrequency plus genicular nerve block with bupivacaine plus corticosteroid versus intraarticular Hyaluronic acid injections, in terms of clinical and functional parameters, in patients with knee osteoarthritis.
The 2 groups in the trial
- Hyaluronic Acid groupTreatment being tested
Patients underwent intra-articular hyaluronic acid injection.
Treatment: Hyaluronic acid
- Transcutaneous pulsed radiofrequency groupTreatment being tested
Patients underwent transcutaneous pulsed radiofrequency application plus genicular nerve block.
Treatment: Transcutaneous pulsed radiofrequency
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Comparative Study Between Transcutaneous Pulsed Radiofrequency Application Plus Genicular Nerve Block Versus Intra-Articular Hyaluronic Acid Injection for Management of Chronic Pain in Knee Osteo-arthritis: A Prospective Randomized Controlled Study.
- Record updated
- 29 November 2024